Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Feb 27, 2021; 13(2): 210-221
Published online Feb 27, 2021. doi: 10.4240/wjgs.v13.i2.210
Published online Feb 27, 2021. doi: 10.4240/wjgs.v13.i2.210
Table 1 Characteristics of the study population in the train set and validation set
| Characteristics | Train set, n = 175 | Test set, n = 174 | Entire set, n = 349 |
| Age, mean ± SD | 65.38 ± 13.25 | 65.29 ± 13.12 | 65.33 ± 13.19 |
| Sex, male/female | 94/81 | 93/81 | 187/162 |
| Clinical stage, I/II/III/IV | 31/64/55/25 | 34/75/50/15 | 65/139/105/40 |
| Status, deceased/alive | 23/152 | 15/159 | 38/311 |
- Citation: Zong Z, Hu CG, Zhou TC, Yu ZM, Tang FX, Tian HK, Li H, Wang H. Nine-long non-coding ribonucleic acid signature can improve the survival prediction of colorectal cancer. World J Gastrointest Surg 2021; 13(2): 210-221
- URL: https://www.wjgnet.com/1948-9366/full/v13/i2/210.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i2.210